Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cellbxhealth Plc ADR (ANPCY)

Cellbxhealth Plc ADR (ANPCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0666 +0.60%
on 12/22/25
0.2165 -69.05%
on 12/01/25
-0.1371 (-67.17%)
since 11/28/25
3-Month
0.0666 +0.60%
on 12/22/25
0.4325 -84.51%
on 10/27/25
-0.2353 (-77.84%)
since 09/29/25
52-Week
0.0666 +0.60%
on 12/22/25
2.3900 -97.20%
on 02/04/25
-1.2830 (-95.04%)
since 12/18/24

Most Recent Stories

More News
Angle PLC Announces Results of Eisai Phase 2 pilot study

UPDATE ON ASTRAZENECA ASSAY DEVELOPMENT PROJECTS AND SUCCESSFUL COMPLETION OF EISAI CONTRACT

ANPCY : 0.0670 (-2.62%)
AGL : 0.5528 (-7.03%)
Angle PLC Announces Issue of LTIP Options and Share Options

GUILDFORD, SURREY / ACCESS Newswire / March 21, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that, under the Remuneration Policy approved by the shareholders...

ANPCY : 0.0670 (-2.62%)
AGL : 0.5528 (-7.03%)
Angle PLC Announces Analysis of CTC-DNA and ctDNA using Illumina assay

NEW RESULTS FOR dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform

ANPCY : 0.0670 (-2.62%)
AGL : 0.5528 (-7.03%)
Angle PLC Announces Parsortix Used in Research Paper from ETH Zurich

CLINICAL TRIAL POWERED BY PARSORTIX SYSTEM PROVIDES FIRST-IN-CLASS data FOR NOVEL APPROACH TO CANCER treatment

ANPCY : 0.0670 (-2.62%)
AGL : 0.5528 (-7.03%)
Angle PLC Announces Trading Update

Revenue for 2024 expected to be up 31%

ANPCY : 0.0670 (-2.62%)
AGL : 0.5528 (-7.03%)
Angle PLC Announces HER2 Presentation at SABCS

WEILL CORNELL MEDICINE PRESENTS HER2 PARSORTIX WORKFLOW AT SAN ANTONIO BREAST CANCER SYMPOSIUM

ANPCY : 0.0670 (-2.62%)
AGL : 0.5528 (-7.03%)
ANGLE presents two posters at EACR

PARSORTIX-BASED ASSAYS SHOWCASED AT THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH LIQUID BIOPSIES CONFERENCE

ANPCY : 0.0670 (-2.62%)
AGL : 0.5528 (-7.03%)
Angle PLC Announces Publication Demonstrates CTC Profiling Potential

PUBLICATION DEMONSTRATES POTENTIAL FOR multi-marker CTC profiling IN EARLY PROSTATE CANCER

ANPCY : 0.0670 (-2.62%)
AGL : 0.5528 (-7.03%)
Angle PLC Announces Issue of Equity

Exercise of Options and Total Voting Rights

ANPCY : 0.0670 (-2.62%)
AGL : 0.5528 (-7.03%)
Angle PLC Announces Result of 2022 Annual General Meeting

GUILDFORD, SURREY / ACCESSWIRE / June 29, 2022 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier today,...

ANPCY : 0.0670 (-2.62%)
AGL : 0.5528 (-7.03%)

Business Summary

ANGLE PLC was incorporated on December 04, 2003 in England and Wales. It is a commercially driven specialist medical diagnostic company with products in cancer diagnostics and foetal health. The Company is commercializing a platform technology that can capture cells circulating in blood, such as cancer...

See More

Key Turning Points

3rd Resistance Point 0.0687
2nd Resistance Point 0.0683
1st Resistance Point 0.0677
Last Price 0.0670
1st Support Level 0.0667
2nd Support Level 0.0663
3rd Support Level 0.0657

See More

52-Week High 2.3900
Fibonacci 61.8% 1.5025
Fibonacci 50% 1.2283
Fibonacci 38.2% 0.9541
Last Price 0.0670
52-Week Low 0.0666

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar